Concentration of mass-production operations in Shanghai, China
First written in FY2016. 8 of 17 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2022: 27 of 56 companies on the "Worse" side.
13 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「In addition, the Company began operating a new plant in Akita, Japan's second mass-production site, in April 2025, and will strengthen the diversification of production sites, local production for local consumption, and BCP measures.」
To address the concentration risk in the Shanghai and Chinese production subsidiaries, the Akita Plant began operations in April 2025, bringing the diversification of production sites, local production for local consumption and BCP strengthening to the implementation stage. - FY2025-H1MitigatedAnnual report
「Liabilities increased by ¥4,723 million from the end of the previous consolidated fiscal year to ¥24,562 million, mainly due to an increase in borrowings to fund construction of the new Akita plant.」
The Group disclosed an increase in borrowings to fund construction of the new Akita plant, indicating that measures to strengthen its multi-site production structure have entered the implementation phase with financing in place. - FY2023-Q3MaterialisedAnnual report
「The Group recorded ¥365 million as an extraordinary loss for the impact of the suspension of operations at its Shanghai production subsidiary due to the lockdown in the first quarter.」
The risk associated with concentrating mass-production operations in Shanghai continues to materialize in the form of the suspension of operations at the Shanghai production subsidiary and the recognition of a ¥365 million extraordinary loss. - FY2023-Q2MaterialisedAnnual report
「The Group recorded ¥367 million as an extraordinary loss for the impact of the suspension of operations at its Shanghai production subsidiary due to the lockdown in the first quarter.」
The risk associated with concentrating mass-production operations in Shanghai continues to materialize in the form of the suspension of operations at the Shanghai production subsidiary and the recognition of a ¥367 million extraordinary loss. - FY2023-Q1MaterialisedAnnual report
「The Group recorded ¥363 million as an extraordinary loss for the impact of the suspension of operations at its Shanghai production subsidiary due to the lockdown.」
The risk associated with concentrating mass-production operations in Shanghai materialized in the form of the suspension of operations at the Shanghai production subsidiary and the recognition of a ¥363 million extraordinary loss. - FY2022MitigatedAnnual report
「The company is also constructing a new plant in Akita, which will be its second mass-production site in Japan, with operations targeted to begin in 2025, thereby further strengthening its multi-site production system.」
To address the risk of concentrating mass production in Shanghai, the Group presented plans for a second mass-production site in Akita targeted to begin operations in 2025, setting out specific measures to strengthen its multi-site production structure. - FY2022-Q3RestatedAnnual report
「During the nine-month cumulative period, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」
The Group states that there have been no material changes regarding the risk of concentrating mass production operations in Shanghai, China. - FY2021RestatedAnnual report
「Except for products manufactured across multiple sites at the Ibaraki plant, the Philippine production subsidiary and the Vietnamese production subsidiary, production is concentrated at the Group's Shanghai production subsidiary in China. If an unforeseen event caused by any factor makes operations at these production sites impossible, the Group's operating results and financial condition could be affected. However, the Group established a Nantong production subsidiary in September 2016 to rebuild its mass-production network. The Mexican production subsidiary established in March 2016 is not contributing to production at present, but the Group expects it to become an important production site in the future.」
The Group continues to disclose the risk of concentrating production in Shanghai, identifying rebuilding through Nantong and the future establishment of a production site in Mexico as countermeasures. - FY2020-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The Group states that there have been no material changes regarding the risk of concentrating mass production operations in Shanghai, China. - FY2020-Q1RestatedAnnual report
「During the three-month cumulative period, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」
The Group states that there have been no material changes regarding the risk of concentrating mass production operations in Shanghai, China. - FY2019RestatedAnnual report
「Except for products manufactured across multiple sites at the Ibaraki plant, the Philippine production subsidiary and the Vietnamese production subsidiary, production is concentrated at the Group's Shanghai production subsidiary in China. The Group established a Mexican production subsidiary in March 2016 and a Nantong production subsidiary in September 2016, with a view to rebuilding its mass-production network, and will also consider outsourcing manufacturing and transitioning to a fabless model as necessary. However, if an unforeseen event caused by any factor makes operations at these production sites impossible, the Group's operating results and financial condition could be affected.」
The Group continues to disclose the risk of concentrating production in Shanghai and the measures to rebuild its mass-production network through Mexico and Nantong. - FY2019-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The Group states that there have been no material changes regarding the risk of concentrating mass production operations in Shanghai, China. - FY2019-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The Group states that there have been no material changes regarding the risk of concentrating mass production operations in Shanghai, China. - FY2019-Q1MitigatedAnnual report
「On the production side, the Nantong Plant in China (南通意力速電子工業有限公司) commenced operations in April as part of efforts to strengthen production capacity under the medium-term management plan.」
The Nantong Plant began operations, moving from the stage previously described, in which it had not manufactured or supplied products even after its establishment, to the operating stage. Diversification measures addressing the concentration of the mass-production base in Shanghai have progressed in implementation, but the disclosure does not state that the risk has been eliminated. - FY2018-Q3RestatedAnnual report
「During the nine-month cumulative period, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」
The Company states that there have been no material changes in the risk associated with the concentration of the mass-production base in Shanghai, China disclosed in the previous fiscal year. - FY2017MitigatedAnnual report
「The Company established a Mexican production subsidiary in March 2016 and a Nantong production subsidiary in September 2016. While rebuilding its mass-production base, the Company will also consider, as necessary, adopting an asset-light, fabless model through contract manufacturing and other measures. However, if an unforeseen event caused by any factor makes operations at those production sites impossible, the Group's operating results and financial position may be affected.」
The establishment of production subsidiaries in Mexico and Nantong provided concrete measures to address the concentration in Shanghai. However, neither company manufactured or supplied products during the consolidated fiscal year, and the disclosure does not state that the concentration risk had been eliminated. - FY2016First statedAnnual report
「Except for products manufactured at multiple sites, including the Ibaraki Plant, the Philippine production subsidiary and the Vietnamese production subsidiary, the Group's production is concentrated at its Shanghai production subsidiary in China. The Group plans to rebuild its mass-production base and will consider, as necessary, adopting an asset-light, fabless model through contract manufacturing and other measures. However, if an unforeseen event caused by any factor makes operations at those production sites impossible, the Group's operating results and financial position may be affected.」
Recognized the concentration of mass production in Shanghai and considered rebuilding the production base and adopting a fabless model.